Skip to main content

Table 1 Baseline characteristics

From: Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients

  

Body Mass Index

 
 

Total

Normal or underweight

Overweight

Obese

p-value*

≤ 22.9 kg/m2

23–24.9 kg/m2

≥ 25 kg/m2

 

N (%)

N (%)

N (%)

N (%)

 

Total

522 (100)

184 (35.2)

152 (29.1)

186 (35.6)

 

Age

    

0.028

  < 65 years

366 (70.1)

138 (75.0)

108 (71.1)

120 (64.5)

0.42

  ≥ 65 years

156 (29.9)

46 (25.0)

44 (28.9)

66 (35.5)

0.028

Sex

    

0.094

 Male

312 (59.8)

99 (53.8)

97 (63.8)

116 (62.4)

0.064

 Female

210 (40.2)

85 (46.2)

55 (36.2)

70 (37.6)

0.095

Location

    

0.56

 Proximal

181 (34.7)

63 (34.2)

49 (32.2)

69 (37.1)

0.70

 Distal

341 (65.3)

121 (65.8)

103 (67.8)

117 (62.9)

0.57

T stage

    

0.17

 T1 - 3

446 (85.4)

149 (81.0)

137 (90.1)

160 (86.0)

0.019

 T4

76 (14.6)

35 (19.0)

15 (9.9)

26 (14.0)

0.19

N stage

    

0.96

 N0 - 1

380 (72.8)

133 (72.3)

113 (74.3)

134 (72.0)

0.67

 N2

142 (27.2)

51 (27.7)

39 (25.7)

52 (28.0)

0.96

Tumor stage

   

0.073

 II, high-risk

78 (14.9)

37 (20.1)

16 (10.5)

25 (13.4)

0.016

 III

444 (85.1)

147 (79.9)

136 (89.5)

161 (86.6)

0.086

Histology

    

0.15

 MAC

27 (5.2)

12 (6.5)

9 (5.9)

6 (3.2)

0.82

 Non-MAC

495 (94.8)

172 (93.5)

143 (94.1)

180 (96.8)

0.14

Microsatellite status (N = 517)

0.062

 MSS/MSI-L

480 (92.8)

163 (90.1)

142 (93.4)

175 (95.1)

0.27

 MSI-H

37 (7.2)

18 (9.9)

10 (6.6)

9 (4.9)

0.065

  1. Abbreviations: MAC mucinous adenocarcinoma, MSS microsatellite stable, MSI-L microsatellite instability-low, MSI-H microsatellite instability-high
  2. *Upper row: linear-by-linear association test, middle row: Χ2 test of normal or underweight vs. overweight, lower row: Χ2 test of normal or underweight vs. obese
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us